109 related articles for article (PubMed ID: 884662)
1. Immunochemotherapy of transplanted KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes.
Akiyama J; Kawamura T; Gotohda E; Yamada Y; Hosokawa M; Kodama T; Kobayashi H
Cancer Res; 1977 Sep; 37(9):3042-5. PubMed ID: 884662
[TBL] [Abstract][Full Text] [Related]
2. Diminution of cyclophosphamide-induced suppression of antitumor immunity by an immunomodulator PS-K and combined therapeutic effects of PS-K and cyclophosphamide on transplanted tumor in rats.
Mizushima Y; Yuhki N; Hosokawa M; Kobayashi H
Cancer Res; 1982 Dec; 42(12):5176-80. PubMed ID: 7139621
[TBL] [Abstract][Full Text] [Related]
3. Effect of combination treatment with cyclophosphamide and nonspecific passive immunization on a transplantable tumor in WKA rats.
Gotohda E; Kawamura T; Sendo F; Nakayama M; Akiyama J
Cancer Res; 1976 Jul; 36(7 PT 1):2119-23. PubMed ID: 1277122
[TBL] [Abstract][Full Text] [Related]
4. Effect of normal allogeneic lymphoid cell transfer in combination with chemotherapy on a transplantable tumor in rats.
Yamada Y; Kawamura T; Gotohda E; Akiyama J; Hosokawa M; Kodama T; Kobayashi H
Cancer Res; 1980 Mar; 40(3):954-8. PubMed ID: 6781744
[TBL] [Abstract][Full Text] [Related]
5. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
Naito K; Pellis NR; Kahan BD
Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
[TBL] [Abstract][Full Text] [Related]
6. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Sugawara M; Kobayashi H
Cancer Res; 1985 Apr; 45(4):1502-6. PubMed ID: 2579730
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic effect of the antileukemia drug busulfan as an immunomodulator on transplanted fibrosarcoma KMT-17 in WKA rats.
Mizushima Y; Koga Y; Yuhki N; Kobayashi H
Gan; 1983 Feb; 74(1):162-8. PubMed ID: 6840435
[TBL] [Abstract][Full Text] [Related]
8. Effect of thermochemotherapy (combined cyclophosphamide and hyperthermia) given at various temperatures with or without glucose administration on a murine fibrosarcoma.
Urano M; Kim MS; Kahn J; Kenton LA; Li ML
Cancer Res; 1985 Sep; 45(9):4162-6. PubMed ID: 4028008
[TBL] [Abstract][Full Text] [Related]
9. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
Mizushima Y; Sendo F; Miyake T; Kobayashi H
J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
[TBL] [Abstract][Full Text] [Related]
11. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta K; Tanaka T; Takeuchi M
Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
[TBL] [Abstract][Full Text] [Related]
13. [Enhancement of antitumor immune responses by bleomycin].
Morikawa K
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):772-80. PubMed ID: 2467868
[TBL] [Abstract][Full Text] [Related]
14. [Immunological analysis of chemotherapeutic effects for the effective immunochemotherapy against cancer].
Yamada Y
Hokkaido Igaku Zasshi; 1984 Nov; 59(6):721-7. PubMed ID: 6397415
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2.
Naito K; Nomi S; Komichi H; Ueda Y; Yamagishi H; Oka T; Pellis NR; Kahan BD
Cancer Detect Prev; 1992; 16(5-6):321-7. PubMed ID: 1361881
[TBL] [Abstract][Full Text] [Related]
16. [New direction in immunochemotherapy of cancer].
Nitta K
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1117-28. PubMed ID: 6191674
[TBL] [Abstract][Full Text] [Related]
17. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
18. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
Mokyr MB; Dray S
Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery.
Shibata T; Yamashita T; Suzuki K; Takeichi N; Micallef M; Hosokawa M; Kobayashi H; Murata M; Arisue M
Anticancer Res; 1998; 18(6A):4443-8. PubMed ID: 9891507
[TBL] [Abstract][Full Text] [Related]
20. [Enhancement of immune response by an antitumor agent, cyclophosphamide].
Nitta K; Tanaka T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):706-13. PubMed ID: 2938546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
